Literature DB >> 2688298

Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors.

C Prehaud1, K Takehara, A Flamand, D H Bishop.   

Abstract

The gene encoding the glycoprotein of rabies virus (G protein, CVS strain) has been cloned and inserted into the baculovirus transfer vector pAcYM1 derived from the nuclear polyhedrosis virus of Autographa californica (AcNPV). The gene was placed under the control of the AcNPV polyhedrin promoter and expressed to high levels by the derived recombinant virus using a Spodoptera frugiperda cell line. It has been established that the antigenic characteristics of the protein were conserved by comparison with those of the native glycoprotein of rabies virions. The immunogenicity of the expressed product was also demonstrated. Intraperitoneal or intramuscular injection of G antigen conferred protection to mice and was associated with the induction of high titers of neutralizing antibodies. The availability of large quantities of antigenically and immunogenically reactive rabies G protein may make feasible crystallographic studies and the safe preparation of a low cost subunit vaccine for the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688298     DOI: 10.1016/0042-6822(89)90551-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.

Authors:  R Ramya; B Mohana Subramanian; V Sivakumar; R L Senthilkumar; K R S Sambasiva Rao; V A Srinivasan
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 2.  Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies.

Authors:  Sergio Rosales-Mendoza
Journal:  Mol Biotechnol       Date:  2015-10       Impact factor: 2.695

3.  Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

Authors:  H Ghiasi; A B Nesburn; R Kaiwar; S L Wechsler
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

Authors:  C Naftzger; Y Takechi; H Kohda; I Hara; S Vijayasaradhi; A N Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 5.  The glycoprotein G of rhabdoviruses.

Authors:  J M Coll
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Secretion of truncated recombinant rabies virus glycoprotein with preserved antigenic properties using a co-expression system in Hansenula polymorpha.

Authors:  Weidong Qian; Frank Aguilar; Ting Wang; Bingsheng Qiu
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

7.  Characterization of rabies glycoprotein expressed in yeast.

Authors:  S R Klepfer; C Debouck; J Uffelman; P Jacobs; A Bollen; E V Jones
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.

Authors:  C Tuffereau; J Bénéjean; D Blondel; B Kieffer; A Flamand
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

9.  A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.

Authors:  H Le Blois; P Roy
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Novel vaccines to human rabies.

Authors:  Hildegund C J Ertl
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.